A quantitative treatment assessment for optimizing combined virotherapy-chemotherapy regimens against HPV-induced cervical cancer. [PDF]
Ghosh S +5 more
europepmc +1 more source
Virotherapy for Spinal and Spinal Cord Tumors: Current Evidence and Future Perspectives. [PDF]
Uotani K +9 more
europepmc +1 more source
Precision virotherapy for IDH-mutant astrocytoma. [PDF]
Panagioti E +4 more
europepmc +1 more source
Emerging and Re-Emerging Viral Pathogens in Oncolytic Virotherapy: A Comprehensive Review. [PDF]
An X, Liu N, Liu J.
europepmc +1 more source
Oncolytic virotherapy is one of the cancer treatments that kills cancer cells but leaves normal cells. Furthermore, mitogen-activated protein kinase (MEK) inhibitors boost chimeric antigen receptor expression and increase oncolytic virus entry into tumor
Daengkongkho Salinthip +1 more
core +1 more source
In situ APMV-4 vaccination primes systemic response to subtherapeutic dosing of aCTLA-4 in colorectal carcinoma. [PDF]
Bykov Y +10 more
europepmc +1 more source
Therapy-induced IGF1R signaling as an actionable vulnerability in oncolytic virotherapy. [PDF]
Miller AA, Lee TJ, Yoo JY.
europepmc +1 more source
Advances and Future Expectations in Oncolytic Virus Therapy for Glioblastoma: A Systematic Review of Clinical Trials. [PDF]
Kenaan N +8 more
europepmc +1 more source
Oncolytic virotherapy counteracts the selection of IFN-unresponsive cancer cells post-immunotherapy but is limited by the emergence of dedifferentiated cancer cells. [PDF]
Gellert S +5 more
europepmc +1 more source
Treatment Strategies for Advanced Cutaneous Squamous Cell Carcinoma Following Anti-PD-1 Immunotherapy Failure: A Systematic Review of the Literature and Ongoing Trials. [PDF]
Thomson H +4 more
europepmc +1 more source

